NeutraKine® IL-6 Monoklonaler Antikörper

NeutraKine® IL-6 Monoklonal Antikörper für IHC, Neutralization, ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human und mehr (1)

Anwendung

IHC, IF, Neutralization, ELISA

Konjugation

Unkonjugiert

Publikationen(10)

CloneNo.

4G3E6

Kat-Nr. : 69001-1-Ig

Synonyme

IL6, IL-6, 4G3E6, B-cell stimulatory factor 2, IFN-beta-2



Neutralization

Veröffentlichte Anwendungen

IFSee 1 publications below
ELISASee 1 publications below

Produktinformation

69001-1-Ig bindet in IHC, IF, Neutralization, ELISA NeutraKine® IL-6 und zeigt Reaktivität mit human

Getestete Reaktivität human
In Publikationen genannte Reaktivitäthuman, Ratte
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen human Humankine IL-6 protein HZ-1019
Vollständiger Name interleukin 6 (interferon, beta 2)
Gene symbol IL6
Gene ID (NCBI) 3569
Konjugation Unkonjugiert
Form Lyophilized Powder
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer Sterile PBS
Endotoxin<0.1 EU/μg
WiederherstellungThis product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
Stability and StorageLyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

Hintergrundinformationen

Interleukin-6 (IL-6) is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine. IL-6 protein is secreted by a variety of cell types including T cells and macrophages as phosphorylated and variably glycosylated molecule. IL-6 plays an essential role in the final differentiation of B-cells into Ig-secreting cells involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. IL-6 is also considered a myokine, a cytokine produced from muscle, and is elevated in response to muscle contraction. IL-6 has been shown to interact with interleukin-6 receptor and glycoprotein 130. Additionally, IL-6 is involved in hematopoiesis, bone metabolism, and cancer progression, and has been defined an essential role in directing transition from innate to acquired immunity.

This antibody can be used to neutralize the bioactivity of IL-6.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
IHC protocol for NeutraKine® IL-6 antibody 69001-1-IgProtokoll herunterladenl
FC protocol for NeutraKine® IL-6 antibody 69001-1-IgDownload protocol
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanNeutralization

Oncogene

LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling

Authors - Yuxi Ma
humanIF

Front Immunol

Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma

Authors - Dongqing Gu
humanELISA

Free Radic Biol Med

IRF1/ZNF350/GPX4-mediated ferroptosis of renal tubular epithelial cells promote chronic renal allograft interstitial fibrosis

Authors - Yao Zhang
humanNeutralization

Int J Biol Sci

The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.

Authors - Wentao Liu
humanNeutralization

Biomed Pharmacother

Interleukin-6 neutralizing antibody attenuates the hypersecretion of airway mucus via inducing the nuclear translocation of Nrf2 in chronic obstructive pulmonary disease.

Authors - Yuan-Yuan Wei
rat

J Biochem Mol Toxicol

Uric acid promotes interleukin-17 expression to cause kidney injury

Authors - Lina Yang